{
    "SPADE_UN_28415": {
        "Sequence Information": {
            "Peptide Name": "H/V-peptide (1-11)(19-25)[K4N]",
            "Sequence": "GILNTIKSIASKLKRKAK",
            "Sequence Length": 18,
            "Biological Activity": [
                "Anti-Gram-",
                "Antiparasitic",
                "Anti-Mammalian Cell"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [
                {
                    "uniprotId": "P82656",
                    "uniprotUrl": "http://www.uniprot.org/uniprot/P82656",
                    "description": "The amino acid sequence of the current peptide coincides with the amino acid sequence of the UniProt entry."
                },
                {
                    "uniprotId": "F1AWB0",
                    "uniprotUrl": "http://www.uniprot.org/uniprot/F1AWB0",
                    "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."
                }
            ],
            "Literature": [
                {
                    "Title": "Enhanced antimicrobial activity of novel synthetic peptides derived from vejovine and hadrurin.",
                    "Pubmed ID": "23403131",
                    "Reference": "Biochim Biophys Acta. 2013;1830:3427-3436",
                    "Author": "Sánchez-Vásquez L, Silva-Sanchez J, Jiménez-Vargas JM, Rodríguez-Romero A, Muñoz-Garay C, Rodríguez MC, Gurrola GB, Possani LD",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/23403131"
                }
            ],
            "Mass": 1969.42,
            "PI": 11.39,
            "Net Charge": 6,
            "Hydrophobicity": -0.31,
            "Frequent Amino Acids": "KIA",
            "Absent Amino Acids": "CDEFHMOPQUVWY",
            "Basic Residues": 6,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 7,
            "Polar Residues": 11,
            "Positive Residues": 6,
            "Negative Residues": 0,
            "SPADE ID": "SPADE_UN_28415",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_09708",
                    "Similarity": 1.0,
                    "Sequence": "IKSIASKVANTVQKLKRKAKNAV"
                },
                {
                    "SPADE_ID": "SPADE_N_09709",
                    "Similarity": 1.0,
                    "Sequence": "IKSIASKVANTVQKLKRKAKNAVA"
                },
                {
                    "SPADE_ID": "SPADE_UN_28408",
                    "Similarity": 1.0,
                    "Sequence": "IKSIASKVANTVQKLKRKAKNAV"
                }
            ],
            "Hemolytic Activity": "Human erythrocytes:50% Hemolysis=640 µM,Human embryonic kidney HEK293 cells:50% Cell death=139 µM,Human COS-7 cells:50% Cell death=123 µM",
            "Target Organism": "Escherichia coli ATCC 25922(MIC=1.56µM),Escherichia coli 170(MIC=1.56µM),Escherichia coli 4530(MIC=>50µM),Enterobacter cloacae 2524(MIC=>50µM),Enterobacter cloacae 6780(MIC=3.12µM),Klebsiella pneumoniae 913(MIC=6.25µM),Pseudomonas aeruginosa 4677(MIC=>50µM),Acinetobacter baumannii(MIC=1.56-3.12µM),Streptococcus pneumoniae ATCC 49619(MIC=50µM),Salmonella typhimurium(MIC=3.1-6.2µM),Plasmodium berghei(40-50% Inhibition=5µM),Klebsiella pneumoniae 1625(MIC=3.12µM)"
        }
    }
}